1. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice
   Nam-Chul Jung et al, 2016, Immunological Investigations CrossRef
2. Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
   Jeong-Hoon Lee et al, 2017, OncoImmunology CrossRef
3. Immunotherapy in Gastrointestinal Cancers
   Letizia Procaccio et al, 2017, BioMed Research International CrossRef
4. Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine-induced killer cell therapy in hepatobiliary and pancreatic cancer
   LIHONG ZHANG et al, 2016 CrossRef
5. Systemic therapy for hepatocellular carcinoma (HCC): from bench to bedside.
   Omar Abdel-Rahman, 2013, J Egypt Natl Canc Inst CrossRef
6. GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth
   CHENHONG LUO et al, 2014 CrossRef
7. Integrative genomic analyses of a novel cytokine, interleukin-34 and its potential role in cancer prediction
   Bo Wang et al, 2014, Int J Mol Med CrossRef
8. Potentiality of immunotherapy against hepatocellular carcinoma
   Nobuhiro Tsuchiya, 2015, WJG CrossRef
9. Current status and perspectives of immune-based therapies for hepatocellular carcinoma
   Maridi Aerts, 2016, WJG CrossRef
10. Vaccine Approaches in Hepatocellular Carcinoma
    Maria Tagliamonte et al, 2017 CrossRef
11. Current immunotherapeutic strategies in hepatocellular carcinoma: recent advances and future directions
    Hwi Young Kim et al, 2017, Therap Adv Gastroenterol CrossRef
12. Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA
    Mutita Junking et al, 2017, Tumour Biol. CrossRef
13. STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC
    Qiuju Han et al, 2017, J Exp Clin Cancer Res CrossRef
14. Immunotherapy for hepatocellular carcinoma: From basic research to clinical use.
    Yu-Peng Hong et al, 2015, World J Hepatol CrossRef
15. Evolving Immunotherapy Approaches for Hepatocellular Carcinoma
    Ken Takahashi et al, 2018 CrossRef
16. Development of effective tumor immunotherapy using a novel dendritic cell–targeting Toll-like receptor ligand
    Nadeeka H. De Silva et al, 2017, PLoS ONE CrossRef
17. Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
    ZHEN-HAI ZHANG et al, 2014 CrossRef
18. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
    Thomas Tu et al, 2014, IJMS CrossRef
19. Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
    Christian Lehmann et al, 2016, Vaccines CrossRef
20. δ-Catenin Peptide Vaccines Repress Hepatocellular Carcinoma Growth via CD8+ T Cell Activation
    Fei Huang et al, 2018, OncoImmunology CrossRef
21. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity
    Xiaoping Wang et al, 2018, Canadian Journal of Gastroenterology and Hepatology CrossRef
22. Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma
    Naofumi Mukaida et al, 2018, WJG CrossRef
23. Systems Challenges of Hepatic Carcinomas: A Review
    Dhatri Madduru et al, 2018, Journal of Clinical and Experimental Hepatology CrossRef
24. Dendritic Cell Therapy
    Farhad Dastmalchi et al, 2018 CrossRef
25. Junctional adhesion molecules mediate transendothelial migration of dendritic cell vaccine in cancer immunotherapy
    Seung-Eon Roh et al, 2018, Cancer Letters CrossRef
26. Challenges and Opportunities in the Clinical Development of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
    Michael J. Flynn et al, 2019, Hepatology CrossRef
27. A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
    Jeong-Hoon Lee et al, 2015, Br J Cancer CrossRef
28. Immunological landscape and immunotherapy of hepatocellular carcinoma
    Jesús Prieto et al, 2015, Nat Rev Gastroenterol Hepatol CrossRef
29. Cancer Immunotherapy Confers a Global Benefit
    Zahra Aryan et al, 2015 CrossRef
30. Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.
    Yu Jiang et al, 2019, World J Gastroenterol CrossRef
31. The dendritic cell
    Jatin M. Vyas, 2012, Virulence CrossRef
32. Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine
    Maolei Xu et al, 2013, Tumor Biol. CrossRef
33. Trial watch
    Erika Vacchelli et al, 2013, OncoImmunology CrossRef
34. Tumour Immunogenicity, Antigen Presentation, and Immunological Barriers in Cancer Immunotherapy
    David Escors, 2014, New Journal of Science CrossRef
35. Immune therapy for hepatocellular carcinoma
    Yaron Ilan, 2014, Hepatol Int CrossRef
36. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Vinicio Carloni et al, 2014, Liver Int CrossRef
37. Agonistic anti-CD137 antibody treatment leads to antitumor response in mice with liver cancer
    Vanessa Gauttier et al, 2014, Int. J. Cancer CrossRef
38. An AutologousIn SituTumor Vaccination Approach for Hepatocellular Carcinoma. 1. Flt3 Ligand Gene Transfer Increases Antitumor Effects of a Radio-Inducible Suicide Gene Therapy in an Ectopic Tumor Model
    Yujo Kawashita et al, 2014, Radiation Research CrossRef
39. Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects
    Yukai He et al, 2014, Immunotherapy CrossRef
40. Preservation of cell-based immunotherapies for clinical trials
    RUI LI et al, 2019, Cytotherapy CrossRef
41. Antigen-loaded Dendritic Cell Migration: MR Imaging in a Pancreatic Carcinoma Model
    Zhuoli Zhang et al, 2015, Radiology CrossRef
42. Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinoma.
    Daisuke Hokuto et al, 2015, Eur J Cancer CrossRef
43. Therapeutic Strategies for Hepatocellular Carcinoma: New Advances and Challenges
    Sílvia Vilarinho et al, 2015, Curr Treat Options Gastro CrossRef
44. Specific cellular immune response elicited by the necrotic tumor cell-stimulated macrophages
    Xiaolin Yuan et al, 2015, International Immunopharmacology CrossRef
45. Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial
    Yoshinari Maeda et al, 2015, Cancer Immunol Immunother CrossRef
46. Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model
    Oleg V. Markov et al, 2015, Journal of Controlled Release CrossRef
47. Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
    Oleg V. Markov et al, 2015, PLoS ONE CrossRef
48. Anti-TIM-3 Antibody Prevents Lymphocyte Apoptosis and Enhances Dendritic Cell Cancer Therapy
    Eiichi HAYASHI et al, 2015, Showa Univ J Med Sci CrossRef
49. Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
    James J. Harding et al, 2016, Cancer CrossRef
50. Autologous Tumor Cell Lysate-Loaded Dendritic Cell Vaccine Inhibited Tumor Progression in an Orthotopic Murine Model for Hepatocellular Carcinoma
    Qin Wang et al, 2016, Ann Surg Oncol CrossRef
51. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
    Yaojie Fu et al, 2019, J Exp Clin Cancer Res CrossRef
52. Role of the Immune System in Hepatocellular Carcinoma: Implications for Existing and Novel Therapies
    Tobias Flecken et al, 2016 CrossRef
53. Promising new strategies for hepatocellular carcinoma
    Yasunari Nakamoto, 2017, Hepatol Res CrossRef
54. Cellular immunotherapy of cancer: an overview and future directions
    Ziqi Tao et al, 2017, Immunotherapy CrossRef
55. New vaccination strategies in liver cancer
    Luigi Buonaguro, 2017, Cytokine & Growth Factor Reviews CrossRef
56. Cytolytic Activity of Effector T-lymphocytes Against Hepatocellular Carcinoma is Improved by Dendritic Cells Pulsed with Pooled Tumor Antigens
    Thaweesak Chieochansin et al, 2019, Sci Rep CrossRef
57. Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches
    Maria Tagliamonte et al, 2019, Cancer Letters CrossRef
58. Recent Advances in Immunotherapy for Hepatocellular Carcinoma
    Shigeharu Nakano et al, 2020, Cancers CrossRef
59. A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
    Zhongyi Yan et al, 2016, Oncotarget CrossRef
60. A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma
    Shan-Shan Jiang et al, 2015, Oncotarget CrossRef
61. Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI Radiomics: A Preliminary Investigation
    Aydin Eresen et al, 2020, Academic Radiology CrossRef
62. In�vivo antitumor activity evaluation of cancer vaccines prepared by various antigen forms in a murine hepatocellular carcinoma model
    Chunfeng Si et al, 2017, Oncol Lett CrossRef
63. Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
    Robin Park et al, 2020, Vaccines CrossRef
64. Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.
    Benjamin Ruf et al, 2021, Cell Mol Immunol CrossRef
65. Cancer Immunotherapy Confers a Global Benefit
    Zahra Aryan et al, 2020 CrossRef
66. Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
    Hong Liu et al, 2017, Clin Cancer Res CrossRef
67. Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies
    Ligong Lu et al, 2021, Hepatology CrossRef
68. Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma – 2020 Guangzhou Recommendations
    Qi-Feng Chen et al, 2021, Front. Oncol. CrossRef
69. Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights
    Bahare Shokoohian et al, 2021, J Cell Mol Med CrossRef
70. The Immunology of Hepatocellular Carcinoma
    Gbemisola Lawal et al, 2021, Vaccines CrossRef
71. Immunotherapeutic treatments in hepatocellular carcinoma; achievements, challenges and future prospects
    Raheleh Roudi et al, 2021, International Immunopharmacology CrossRef
72. Potential association factors for developing effective peptide-based cancer vaccines
    Chongming Jiang et al, 2022, Front. Immunol. CrossRef
73. Mesenchymal stem cells-based therapy in liver diseases
    Heng-Tong Han et al, 2022, Mol Biomed CrossRef
74. Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance
    Wei Li et al, 2021, CMC CrossRef
75. Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies
    Long-Bin Jeng et al, 2022, Cancers CrossRef
76. Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases
    Seokhwan Chung et al, 2022, Nanoscale Horiz. CrossRef
77. Immune Microenvironment and Immunotherapeutic Management in Virus-Associated Digestive System Tumors
    Panagiotis Sarantis et al, 2022, IJMS CrossRef
78. Advances in Targeted Immunotherapy for Hepatobiliary Cancers
    Samantha M. Ruff et al, 2022, IJMS CrossRef
79. Highlighting novel targets in immunotherapy for liver cancer
    Samantha M. Ruff et al, 2022, Expert Review of Gastroenterology & Hepatology CrossRef
80. Immunotherapeutic Approaches in Hepatocellular Carcinoma: Building Blocks of Hope in Near Future
    Neda Minaei et al, 2022, European Journal of Cell Biology CrossRef
81. New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?
    Arshi Khanam et al, 2022, IJMS CrossRef
82. Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma
    Carmelo Laface et al, 2023, Cancers CrossRef
83. Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy
    Bahareh Farasati Far et al, 2023, Livers CrossRef
84. Boron Derivatives Inhibit the Proliferation of Breast Cancer Cells and Affect Tumor-Specific T Cell Activity In Vitro by Distinct Mechanisms
    Eslam Essam Mohammed et al, 2023, Biol Trace Elem Res CrossRef
85. Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma
    Pietro Guerra et al, 2023, Cancers CrossRef
86. Advances and considerations in the use of immunotherapies for primary hepato-biliary malignancies
    Leva Gorji et al, 2023, Surgical Oncology CrossRef
87. Development of Immunotherapy for Hepatocellular Carcinoma
    Eishiro Mizukoshi et al, 2015 CrossRef
88. Insights in Molecular Therapies for Hepatocellular Carcinoma
    Philipp Heumann et al, 2024, Cancers CrossRef
89. Comparison of Anti-Trop2 Extracellular Domain Antibodies Generated Against Peptide and Protein Immunogens for Targeting Trop2-Positive Tumour Cells
    Pradnya R. Kamble et al, 2024, Appl Biochem Biotechnol CrossRef
90. Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy.
    Lukas Amon et al, 2020, Pharmaceutics CrossRef
91. A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications
    Carly M. Bliss et al, 2024, Molecular Therapy - Methods & Clinical Development CrossRef
92. Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
    Arnaud Couzinet et al, 2024, Expert Opinion on Therapeutic Targets CrossRef
93. Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease.
    Lei Dou et al, 2018, Semin Liver Dis CrossRef
94. Current Perspectives of Immunotherapy for Hepatocellular Carcinoma
    Xiaoyi Liu et al, 2025, CCHTS CrossRef